
National HealthCare Corporation: shareholders and insiders
Price
$188.55
November 19, 2026Market cap $2.9B
What Ploutos Investor adds for National HealthCare
Part of Ploutos Investor, €9.99 a month
- The full history: 10 fiscal years, from 2016
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 20, 2025 to Sep 23, 2026, from their own Form 4 filings.
Bought on the market
$174.9K
1 person
Sold on the market
$10M
9 people
From Nov 20, 2025 to Nov 20, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan0%
- The rest100%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 20, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $174.9K by 1 person·sold $8.9M by 9 people
- 2025: no buys, sold $1.5M by 3 people
- 2026: bought $174.9K by 1 person, sold $8.9M by 9 people
- Sep 22, 2026Vicki L DodsonSr.VP Patient SrvcsKind
- Sep 11, 2026Brian F KiddSVP, CFOKind
- Sep 10, 2026Josh A McCrearySenior VP & General CounselKind
- Sep 10, 2026Josh A McCrearySenior VP & General CounselKind
- Sep 10, 2026Josh A McCrearySenior VP & General CounselKind
- Sep 10, 2026Josh A McCrearySenior VP & General CounselKind
- Aug 28, 2026Ben Anderson Flatt SrSenior VP & CIOKind
- Aug 25, 2026Ben Anderson Flatt SrSenior VP & CIOKind
- Aug 25, 2026David R. GiffordDirectorKind
- Aug 20, 2026Ben Anderson Flatt SrSenior VP & CIOKind
- Aug 20, 2026David R. GiffordDirectorKind
- Aug 20, 2026David R. GiffordDirectorKind
- Aug 19, 2026Ben Anderson Flatt SrSenior VP & CIOKind
- Aug 19, 2026Stephen Fowler FlattCEOKind
- Aug 17, 2026Ben Anderson Flatt SrSenior VP & CIOKind
- Aug 14, 2026Ben Anderson Flatt SrSenior VP & CIOKind
- Aug 13, 2026David R. GiffordDirectorKind
- Aug 12, 2026Ben Anderson Flatt SrSenior VP & CIOKind
- Jun 22, 2026Emil E HassanDirectorKind
- Jun 16, 2026Brian F KiddSVP, CFOKind
- Jun 16, 2026Emil E HassanDirectorKind
- Jun 8, 2026Robert G AdamsDirectorKind
- Jun 8, 2026Robert G AdamsDirectorKind
- Jun 1, 2026Lisa PierceyDirectorKind
- May 22, 2026Ben Anderson Flatt SrSenior VP & CIOKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 22, 2026 | Vicki L DodsonSr.VP Patient Srvcs | 4,834 | $225.00 | $1.1M | Form 4 | |
| Sep 11, 2026 | Brian F KiddSVP, CFO | 6,813 | $225.70 | $1.5M | Form 4 | |
| Sep 10, 2026 | Josh A McCrearySenior VP & General Counsel | 571 | $222.73 | $127.2K | Form 4 | |
| Sep 10, 2026 | Josh A McCrearySenior VP & General Counsel | 789 | $223.78 | $176.6K | Form 4 | |
| Sep 10, 2026 | Josh A McCrearySenior VP & General Counsel | 1,291 | $225.09 | $290.6K | Form 4 | |
| Sep 10, 2026 | Josh A McCrearySenior VP & General Counsel | 68 | $225.59 | $15.3K | Form 4 | |
| Aug 28, 2026 | Ben Anderson Flatt SrSenior VP & CIO | 1,000 | $222.50 | $222.5K | Form 4 | |
| Aug 25, 2026 | Ben Anderson Flatt SrSenior VP & CIO | 1,000 | $227.00 | $227.0K | Form 4 | |
| Aug 25, 2026 | David R. GiffordDirector | 1,779 | $225.42 | $401.0K | Form 4 | |
| Aug 20, 2026 | Ben Anderson Flatt SrSenior VP & CIO | 1,000 | $237.00 | $237.0K | Form 4 | |
| Aug 20, 2026 | David R. GiffordDirector | 6,479 | $171.42 | $1.1M | Form 4 | |
| Aug 20, 2026 | David R. GiffordDirector | 4,691 | $236.75 | $1.1M | Form 4 | |
| Aug 19, 2026 | Ben Anderson Flatt SrSenior VP & CIO | 1,000 | $237.18 | $237.2K | Form 4 | |
| Aug 19, 2026 | Stephen Fowler FlattCEO | 1,500 | $237.08 | $355.6K | Form 4 | |
| Aug 17, 2026 | Ben Anderson Flatt SrSenior VP & CIO | 1,000 | $226.00 | $226.0K | Form 4 | |
| Aug 14, 2026 | Ben Anderson Flatt SrSenior VP & CIO | 1,000 | $222.11 | $222.1K | Form 4 | |
| Aug 13, 2026 | David R. GiffordDirector | 1,021 | $171.42 | $175.0K | Form 4 | |
| Aug 12, 2026 | Ben Anderson Flatt SrSenior VP & CIO | 1,000 | $221.21 | $221.2K | Form 4 | |
| Jun 22, 2026 | Emil E HassanDirector | 5,937 | $200.00 | $1.2M | Form 4 | |
| Jun 16, 2026 | Brian F KiddSVP, CFO | 500 | – | – | Form 4 | |
| Jun 16, 2026 | Emil E HassanDirector | 1,563 | $199.98 | $312.6K | Form 4 | |
| Jun 8, 2026 | Robert G AdamsDirector | 4,000 | $69.19 | $276.8K | Form 4 | |
| Jun 8, 2026 | Robert G AdamsDirector | 4,000 | – | – | Form 4 | |
| Jun 1, 2026 | Lisa PierceyDirector | 949 | $184.26 | $174.9K | Form 4 | |
| May 22, 2026 | Ben Anderson Flatt SrSenior VP & CIO | 4,000 | $94.10 | $376.4K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before May 27, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by NHC's officers and directors from 2006 up to November 19, 2025, 20 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 15 more, back to 2006
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- BlackRock, Inc.Share of class11.6%
- Morgan Stanleywith 1 more personShare of class7.10%
- Vanguard Portfolio ManagementShare of class5.11%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| BlackRock, Inc. | 11.6% | 1.80M | Oct 17, 2025 | 13G/A | |
| Morgan Stanleywith 1 more person | 7.10% | 1.10M | Mar 12, 2026 | 13G/A | |
| Vanguard Portfolio Management | 5.11% | 794.3K | Apr 29, 2026 | 13G |
Fell to 5% or less (2)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Renaissance TechnologiesIn the quarter-12%
- Millennium Mgmt (Englander)In the quarter
- AQR CapitalIn the quarter+6.1%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Renaissance Technologies | 263.1K | -12% | $58M | 0.08% |
| Millennium Mgmt (Englander) | 5,675 | $1.2M | 0.00% | |
| AQR Capital | 28.8K | +6.1% | $6.3M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 4.86% of its shares outstanding were held short, -7.6% since the report before.
- Shares held short
- 755.0K
- 4.86%
- Since the report before817.2K on Sep 30, 2026
- -7.6%
- 8.9
- 84.6K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 87%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 284.8K
- Nov 15, 2023: Shares held short 289.9K
- Nov 30, 2023: Shares held short 239.1K
- Dec 15, 2023: Shares held short 331.6K
- Dec 29, 2023: Shares held short 778.9K
- Jan 12, 2024: Shares held short 601.6K
- Jan 31, 2024: Shares held short 568.9K
- Feb 15, 2024: Shares held short 486.8K
- Feb 29, 2024: Shares held short 439.6K
- Mar 15, 2024: Shares held short 456.8K
- Mar 28, 2024: Shares held short 520.1K
- Apr 15, 2024: Shares held short 514.0K
- Apr 30, 2024: Shares held short 507.2K
- May 15, 2024: Shares held short 509.8K
- May 31, 2024: Shares held short 510.9K
- Jun 14, 2024: Shares held short 435.1K
- Jun 28, 2024: Shares held short 502.2K
- Jul 15, 2024: Shares held short 401.1K
- Jul 31, 2024: Shares held short 414.0K
- Aug 15, 2024: Shares held short 394.8K
- Aug 30, 2024: Shares held short 411.0K
- Sep 13, 2024: Shares held short 372.1K
- Sep 30, 2024: Shares held short 448.9K
- Oct 15, 2024: Shares held short 369.9K
- Oct 31, 2024: Shares held short 343.2K
- Nov 15, 2024: Shares held short 365.8K
- Nov 29, 2024: Shares held short 349.1K
- Dec 13, 2024: Shares held short 365.8K
- Dec 31, 2024: Shares held short 417.8K
- Jan 15, 2025: Shares held short 344.3K
- Jan 31, 2025: Shares held short 354.3K
- Feb 14, 2025: Shares held short 345.6K
- Feb 28, 2025: Shares held short 343.2K
- Mar 14, 2025: Shares held short 319.6K
- Mar 31, 2025: Shares held short 299.8K
- Apr 15, 2025: Shares held short 255.9K
- Apr 30, 2025: Shares held short 259.6K
- May 15, 2025: Shares held short 221.2K
- May 30, 2025: Shares held short 196.9K
- Jun 13, 2025: Shares held short 260.4K
- Jun 30, 2025: Shares held short 286.5K
- Jul 15, 2025: Shares held short 249.3K
- Jul 31, 2025: Shares held short 256.5K
- Aug 15, 2025: Shares held short 254.3K
- Aug 29, 2025: Shares held short 253.3K
- Sep 15, 2025: Shares held short 259.6K
- Sep 30, 2025: Shares held short 330.3K
- Oct 15, 2025: Shares held short 290.7K
- Oct 31, 2025: Shares held short 294.2K
- Nov 14, 2025: Shares held short 304.2K
- Nov 28, 2025: Shares held short 313.1K
- Dec 15, 2025: Shares held short 326.3K
- Dec 31, 2025: Shares held short 417.5K
- Jan 15, 2026: Shares held short 337.7K
- Jan 30, 2026: Shares held short 377.6K
- Feb 13, 2026: Shares held short 418.4K
- Feb 27, 2026: Shares held short 477.9K
- Mar 13, 2026: Shares held short 581.4K
- Mar 31, 2026: Shares held short 713.4K
- Apr 15, 2026: Shares held short 765.2K
- Apr 30, 2026: Shares held short 690.1K
- May 15, 2026: Shares held short 636.0K
- May 29, 2026: Shares held short 594.6K
- Jun 15, 2026: Shares held short 552.9K
- Jun 30, 2026: Shares held short 790.1K
- Jul 15, 2026: Shares held short 713.1K
- Jul 31, 2026: Shares held short 748.0K
- Aug 14, 2026: Shares held short 756.9K
- Aug 31, 2026: Shares held short 746.8K
- Sep 15, 2026: Shares held short 683.2K
- Sep 30, 2026: Shares held short 817.2K
- Oct 15, 2026: Shares held short 755.0K
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading69.4% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 69.4% of the shares in the reported trades were short sales, against 74.5% in the 14 before.
- Last 14 sessionsNov 2, 2026 – Nov 19, 2026
- 69.4%
- The 14 beforeOct 13, 2026 – Oct 30, 2026
- 74.5%
- Change
- -5.1 pts
- Short sales a dayon average, of 36.6K shares
- 25.4K
- More than atof 3,666 US-listed companies, same days
- 97%
- Median of alleight in ten from 34.5% to 63.8%
- 50.4%
- Short sales
- Oct 13, 2026: Short sales 80.3%
- Oct 14, 2026: Short sales 75%
- Oct 15, 2026: Short sales 77.2%
- Oct 16, 2026: Short sales 73.1%
- Oct 19, 2026: Short sales 82.3%
- Oct 20, 2026: Short sales 61%
- Oct 21, 2026: Short sales 74.9%
- Oct 22, 2026: Short sales 88.5%
- Oct 23, 2026: Short sales 74.7%
- Oct 26, 2026: Short sales 73.9%
- Oct 27, 2026: Short sales 70.4%
- Oct 28, 2026: Short sales 70.1%
- Oct 29, 2026: Short sales 62.4%
- Oct 30, 2026: Short sales 78.9%
- Nov 2, 2026: Short sales 70.5%
- Nov 3, 2026: Short sales 76.4%
- Nov 4, 2026: Short sales 68.5%
- Nov 5, 2026: Short sales 67.9%
- Nov 6, 2026: Short sales 73%
- Nov 9, 2026: Short sales 70.6%
- Nov 10, 2026: Short sales 78.6%
- Nov 11, 2026: Short sales 66.7%
- Nov 12, 2026: Short sales 78.6%
- Nov 13, 2026: Short sales 63.6%
- Nov 16, 2026: Short sales 72.4%
- Nov 17, 2026: Short sales 61%
- Nov 18, 2026: Short sales 70.5%
- Nov 19, 2026: Short sales 48.2%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Robert G AdamsDirectorDirectly443.9K
- Richard F Laroche JrDirectorDirectly205.8K
- Emil E HassanDirectorDirectly65.6K
- Stephen Fowler FlattCEODirectly65.5K
- Brian F KiddSVP, CFODirectly23.2K
- Ben Anderson Flatt SrSenior VP & CIODirectly15.6K
- Vicki L DodsonSr.VP Patient SrvcsDirectly10.7K
- Josh A McCrearySenior VP & General CounselDirectly9,979
- Timothy J. ShellySr.VP OperationsDirectly1,294
- David R. GiffordDirectorDirectly1,030
- Lisa PierceyDirectorDirectly949
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Robert G AdamsDirector | 443.9K | – | Jun 8, 2026 | Form 4 |
| Richard F Laroche JrDirector | 205.8K | – | May 21, 2026 | Form 4 |
| Emil E HassanDirector | 65.6K | – | Jun 22, 2026 | Form 4 |
| Stephen Fowler FlattCEO | 65.5K | – | Aug 19, 2026 | Form 4 |
| Brian F KiddSVP, CFO | 23.2K | – | Sep 11, 2026 | Form 4 |
| Ben Anderson Flatt SrSenior VP & CIO | 15.6K | – | Aug 28, 2026 | Form 4 |
| Vicki L DodsonSr.VP Patient Srvcs | 10.7K | – | Sep 22, 2026 | Form 4 |
| Josh A McCrearySenior VP & General Counsel | 9,979 | – | Sep 10, 2026 | Form 4 |
| Timothy J. ShellySr.VP Operations | 1,294 | – | May 19, 2026 | Form 4 |
| David R. GiffordDirector | 1,030 | – | Aug 25, 2026 | Form 4 |
| Lisa PierceyDirector | 949 | – | Jun 1, 2026 | Form 4 |
A lower bound: it counts only the 11 officers and directors with a market trade since Nov 21, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- SDVYFirst Trust SMID Cap Rising Dividend Achievers ETFWeight in the fund1.19%
- IHFiShares U.S. Healthcare Providers ETFWeight in the fund0.40%
- IJTiShares S&P Small-Cap 600 Growth ETFWeight in the fund0.29%
- SPSMState Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETFWeight in the fund0.14%
- IJRiShares Core S&P Small-Cap ETFWeight in the fund0.14%
- DFSVDimensional US Small Cap Value ETFWeight in the fund0.14%
- IWNiShares Russell 2000 Value ETFWeight in the fund0.12%
- FNDASchwab Fundamental U.S. Small Company ETFWeight in the fund0.10%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.09%
- IWMiShares Russell 2000 ETFWeight in the fund0.09%
26 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 207
- Q4 2025: Managers 222
- Q1 2026: Managers 241
- Q2 2026: Managers 248
Institutional investors by quarter
The fund managers holding NHC, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 248 managers held 10.23M shares, worth $2.2B. During the quarter 39 opened a position, 32 closed one, 87 added and 74 trimmed.
The largest holders, Q2 2026
- BlackRockIn the quarter+4.2%
- Morgan Stanley Institutional Investment AdvisorsIn the quarter-1.0%
- Dimensional Fund AdvisorsIn the quarter-1.8%
- Vanguard Portfolio ManagementIn the quarter+2.5%
- First Trust AdvisorsIn the quarter+38%
- Vanguard Capital ManagementIn the quarter+0.5%
- State StreetIn the quarter+7.2%
- Geode Capital ManagementIn the quarter+18%
- Renaissance TechnologiesIn the quarter-11%
- InvescoIn the quarter+17%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| BlackRock | 1.98M | +4.2% | $418M |
| Morgan Stanley Institutional Investment Advisors | 1.03M | -1.0% | $217M |
| Dimensional Fund Advisors | 929.7K | -1.8% | $196M |
| Vanguard Portfolio Management | 809.2K | +2.5% | $171M |
| First Trust Advisors | 730.6K | +38% | $154M |
| Vanguard Capital Management | 552.1K | +0.5% | $117M |
| State Street | 526.7K | +7.2% | $112M |
| Geode Capital Management | 380.9K | +18% | $81M |
| Renaissance Technologies | 299.7K | -11% | $63M |
| Invesco | 175.3K | +17% | $37M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do National HealthCare's filings show?
Who buys and sells is one part of National HealthCare's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have NHC's insiders bought or sold?
From May 27, 2026 to Sep 23, 2026 National HealthCare's insiders bought $174.9K and sold $7.1M of shares on the market. 0% of the sales were under set 10b5-1 plans.
Which well-known managers hold NHC?
3 of the managers we track held the shares on Sep 30, 2026. The largest position was Renaissance Technologies's, worth $58M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.